- Titre
- Abstract 2852: Obinutuzumab (GA101) efficacy in chronic lymphocytic leukemia in vitro is not diminished in high risk patients.
- Créateurs - sans rôle
- Loic Ysebaert - InsermEmilie Laprevotte - Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier - IRCMChristian Klein - Roche (Switzerland)Jean-Jacques Fournié - Centre de Recherches en Cancérologie de ToulouseAnne Quillet-Mary - Inserm
- Détails de publication
- Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC, pp.2852-2852
- Colloque
- Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC (Washington, United States, 06/04/2013)
- Identifiants
- 9937340609311
- Unité académique
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Langue
- English
- Type de ressource
- Conference proceeding
- Champs locaux
- hal-02348799
Acte de colloque
Abstract 2852: Obinutuzumab (GA101) efficacy in chronic lymphocytic leukemia in vitro is not diminished in high risk patients.
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC, pp.2852-2852
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC (Washington, United States, 06/04/2013)
Indicateurs
1 Consultations de la notice